Modified herpes virus injected into brain to fight deadly tumors
Disease control
Not yet recruiting
This early-stage trial is testing whether a modified herpes virus called C5252 can be safely injected into brain tumors to fight cancer. The study will enroll 36 adults with recurrent malignant brain tumors who have exhausted standard treatments. Researchers will inject the virus…
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC